UK Infectious Disease Diagnostics Market (2025-2030)
The UK Infectious Disease Diagnostics Market was valued at $1280.4 Million in 2025 and projected to reach to $2147.3 Million by 2030, representing a compound annual growth rate of 10.9%. The UK infectious disease diagnostics market is poised for sustained expansion through 2030, driven by increasing infectious disease prevalence, aging population demographics, and heightened biosecurity awareness.
UK Infectious Disease Diagnostics Market Trends and Insights
- The UK market is driven by increasing demand for rapid diagnostic solutions, rising prevalence of infectious diseases, and substantial investment in healthcare infrastructure.
- The UK's advanced laboratory capabilities and regulatory framework position it as a leader in diagnostic innovation within Europe. Between 2025 and 2030, the UK market will benefit from technological advancements in molecular diagnostics, point-of-care testing, and digital health integration.
- The UK's emphasis on early disease detection and pandemic preparedness continues to accelerate adoption of next-generation diagnostic platforms.
- Strong NHS procurement policies and private sector investment further support market expansion across the UK..
Key Market Statistics
- CAGR (2025-2030) 10.9% CAGR
- Market Size, 2025 ~USD 1280.4 Million
- Forecast, 2030 ~USD 2147.3 Million
- Country UK
UK Infectious Disease Diagnostics Market Overview
Market Valuation Growth :
The UK infectious disease diagnostics market is valued at $1,280.4 million in 2025, with a projected expansion to $2,147.3 million by 2030, representing a robust 10.9% CAGR—outpacing the global average of 9.7%.
Rapid Diagnostic Demand :
UK healthcare providers are increasingly adopting rapid point-of-care testing solutions to reduce turnaround times and improve patient outcomes, driven by NHS modernization initiatives and post-pandemic preparedness strategies.
Advanced Regulatory Framework :
The UK's stringent regulatory environment and MHRA oversight ensure high-quality diagnostic products, positioning British manufacturers and importers as trusted suppliers in the European and global markets.
Healthcare Infrastructure Investment :
Substantial UK government funding for laboratory automation, digital pathology, and integrated diagnostic networks is accelerating adoption of next-generation infectious disease testing platforms across NHS trusts and private facilities.
UK Infectious Disease Diagnostics Market Dynamics
- NHS digitalization initiatives and investment in laboratory infrastructure will facilitate adoption of molecular, immunological, and rapid diagnostic technologies.
- The market will benefit from growing demand for multiplex testing, antimicrobial resistance surveillance, and integrated diagnostic solutions that enhance clinical decision-making and reduce healthcare costs across primary, secondary, and tertiary care settings..
Related Ecosystem
In Vitro Diagnostics
Medical Devices
Key Takeaways
- The UK infectious disease diagnostics market will grow from $1,280.4M (2025) to $2,147.3M (2030), representing a 10.9% CAGR.
- The UK market is outpacing global growth, with a 10.9% CAGR compared to the global average of 9.7%, reflecting strong regional demand.
- The UK's advanced healthcare infrastructure and NHS investment drive adoption of molecular diagnostics and point-of-care testing solutions.
- Technological innovation in rapid diagnostics and digital health integration will be key growth catalysts for the UK market through 2030.
Infectious Disease Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MOSQUITO-BORNE DISEASES (Disease Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.7% from 2025 to 2030 |
| Largest Segment | LABORATORY TESTING (Type Of Testing) |
| Market Size Base Year (Billions) | ~USD 26.56 (2025) |
| Revenue Forecast (Billions) | ~USD 42.2 (2030) |
| Segments Covered | Product & Service, Type Of Testing, Sample Type, Disease Type, Type, Technology |
UK Infectious Disease Diagnostics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents, Kits, And Consumables
- Software & Services
By Type Of Testing
- Laboratory Testing
- Poc Testing
By Sample Type
- Blood, Serum, And Plasma
- Other Sample Types
- Urine
By Disease Type
- Chlamydia Trachomatis
- Hepatitis
- Hiv
- Hospital-Acquired Infections
- Hpv
- Influenza
- Mosquito-Borne Diseases
- Neisseria Gonorrhea
- Other Infectious Diseases
- Syphilis
- Tuberculosis
By Type
- Hepatitis B
- Hepatitis C
- Other Hepatitis Diseases
By Technology
- Clinical Microbiology
- Dna Microarray
- Dna Sequencing & Next-Generation Sequencing
- Immunodiagnostics
- Isothermal Nucleic Acid Amplification Technology
- Other Technologies
- Polymerase Chain Reaction
Target Audience
- In Vitro Diagnostics Manufacturers : IVD companies require UK market data to develop localized product strategies, assess market entry feasibility, and identify distribution partnerships with NHS suppliers and private laboratory networks.
- Healthcare System Administrators : NHS trust leaders and hospital procurement teams need market intelligence to evaluate diagnostic technology investments, benchmark laboratory capabilities, and optimize testing workflows and budgets.
- Private Laboratory & Pathology Operators : Independent and private diagnostic providers require UK-specific market forecasts to guide capital investments in equipment, staffing, and service expansion to capture growing demand for infectious disease testing.
- Medical Device Investors & PE Firms : Investment professionals evaluating UK healthcare diagnostics opportunities need validated market sizing, growth projections, and regulatory landscape analysis to assess portfolio company valuations and exit potential.
- Healthcare Consultants & Strategy Firms : Management consultants advising NHS organizations, diagnostic companies, and healthcare investors require authoritative UK market data to support strategic recommendations and competitive analysis.
Key Companies in the UK Infectious Disease Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise UK market valuation ($1,280.4M in 2025) and verified 10.9% CAGR forecasts through 2030 to support investment decisions, business planning, and competitive positioning in the UK diagnostic sector.
- UK-Specific Regulatory Insights : Understand MHRA approval pathways, NHS procurement requirements, and UK-specific compliance standards essential for product launches, market entry strategies, and regulatory risk mitigation.
- NHS & Healthcare Provider Intelligence : Access detailed analysis of NHS trust adoption patterns, laboratory modernization trends, and procurement budgets to identify partnership opportunities and optimize sales strategies for UK healthcare systems.
- Competitive Landscape Analysis : Benchmark against UK-based and international competitors operating in the infectious disease diagnostics space, including market share distribution, product portfolios, and strategic positioning.
- Growth Driver Identification : Leverage UK-specific insights on disease prevalence trends, antimicrobial resistance surveillance programs, and government health initiatives to identify high-growth segments and emerging market opportunities.
Frequently asked questions
What is the current size of the UK infectious disease diagnostics market?
The UK infectious disease diagnostics market is valued at $1,280.4 million in 2025 and is projected to reach $2,147.3 million by 2030.
What is the growth rate of the UK infectious disease diagnostics market?
The UK market is growing at a compound annual growth rate (CAGR) of 10.9% from 2025 to 2030, outpacing the global average of 9.7%.
What factors are driving growth in the UK infectious disease diagnostics market?
Key drivers include rising infectious disease prevalence, demand for rapid diagnostic solutions, NHS procurement initiatives, technological advancements in molecular diagnostics, and pandemic preparedness investments across the UK.
How does the UK market compare to global infectious disease diagnostics trends?
The UK market is growing faster than the global average, with a 10.9% CAGR versus 9.7% globally, driven by strong healthcare infrastructure and regulatory support within the UK.
What diagnostic technologies are most prevalent in the UK market?
The UK market is characterized by adoption of molecular diagnostics, point-of-care testing platforms, immunoassays, and digital health-integrated diagnostic solutions.
RESEARCH METHODOLOGY
The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. The objectives include tracking company developments such as acquisitions, product/service launches & approvals, expansions, agreements, and partnerships of the leading players. These parameters were evaluated on various parameters within the broad business & product strategy categories. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify & collect information for this study.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative & quantitative information for this report. Primary sources included experts from the core & related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain & verify critical qualitative & quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Abbott (US) | Sales Manager |
| Becton, Dickinson and Company (US) | Product Manager |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the infectious disease diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the infectious disease diagnostics market have been determined through primary & secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Infectious disease diagnostics can be defined as various techniques and products (including kits, assays, tests, reagents, and analyzers) used by healthcare professionals to detect and diagnose disease-causing pathogens in human samples such as serum, blood, urine, throat swabs, and stool, among others.
Stakeholders
- Manufacturers & distributors of infectious disease diagnostics
- IVD companies
- Hospitals & clinics
- Academic research institutes
- Diagnostic laboratories
- Blood banks
- Home health agencies
- Market research & consulting firms
- Government associations
- Venture capitalists & investors
Report Objectives
- To define, describe, segment, and forecast the global infectious disease diagnostics market by product & service, type of testing, sample type, disease type, technology, clinical application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall infectious disease diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the infectious disease diagnostics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Get the Full Infectious Disease Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Infectious Disease Diagnostics Market.
- US Infectious Disease Diagnostics Market
- Canada Infectious Disease Diagnostics Market
- Germany Infectious Disease Diagnostics Market
- France Infectious Disease Diagnostics Market
- Italy Infectious Disease Diagnostics Market
- Spain Infectious Disease Diagnostics Market
- China Infectious Disease Diagnostics Market
- Japan Infectious Disease Diagnostics Market
- India Infectious Disease Diagnostics Market
- Brazil Infectious Disease Diagnostics Market
- Mexico Infectious Disease Diagnostics Market
- United Arab Emirates Infectious Disease Diagnostics Market
- Rest Of Europe Infectious Disease Diagnostics Market
- Rest Of Asia Pacific Infectious Disease Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report